Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: An international observational study
Open Access
- 2 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-10
- https://doi.org/10.1186/s13054-020-03431-2
Abstract
Background: Metabolic acidosis is a major complication of critical illness. However, its current epidemiology and its treatment with sodium bicarbonate given to correct metabolic acidosis in the ICU are poorly understood. Method: This was an international retrospective observational study in 18 ICUs in Australia, Japan, and Taiwan. Adult patients were consecutively screened, and those with early metabolic acidosis (pH < 7.3 and a Base Excess < –4 mEq/L, within 24-h of ICU admission) were included. Screening continued until 10 patients who received and 10 patients who did not receive sodium bicarbonate in the first 24 h (early bicarbonate therapy) were included at each site. The primary outcome was ICU mortality, and the association between sodium bicarbonate and the clinical outcomes were assessed using regression analysis with generalized linear mixed model. Results: We screened 9437 patients. Of these, 1292 had early metabolic acidosis (14.0%). Early sodium bicarbonate was given to 18.0% (233/1292) of these patients. Dosing, physiological, and clinical outcome data were assessed in 360 patients. The median dose of sodium bicarbonate in the first 24 h was 110 mmol, which was not correlated with bodyweight or the severity of metabolic acidosis. Patients who received early sodium bicarbonate had higher APACHE III scores, lower pH, lower base excess, lower PaCO2, and a higher lactate and received higher doses of vasopressors. After adjusting for confounders, the early administration of sodium bicarbonate was associated with an adjusted odds ratio (aOR) of 0.85 (95% CI, 0.44 to 1.62) for ICU mortality. In patients with vasopressor dependency, early sodium bicarbonate was associated with higher mean arterial pressure at 6 h and an aOR of 0.52 (95% CI, 0.22 to 1.19) for ICU mortality. Conclusions: Early metabolic acidosis is common in critically ill patients. Early sodium bicarbonate is administered by clinicians to more severely ill patients but without correction for weight or acidosis severity. Bicarbonate therapy in acidotic vasopressor-dependent patients may be beneficial and warrants further investigation.Keywords
Funding Information
- Jikei University School of Medicine (Research Grant)
This publication has 15 references indexed in Scilit:
- Angiotensin II for the Treatment of Vasodilatory ShockThe New England Journal of Medicine, 2017
- Adjust for Multiple Comparisons? It’s Not That SimpleThe Annals of Thoracic Surgery, 2016
- Incidence and long-term outcomes of critically ill adult patients with moderate-to-severe diabetic ketoacidosis: Retrospective matched cohort studyJournal of Critical Care, 2014
- Procurement of shared data instruments for Research Electronic Data Capture (REDCap)Journal of Biomedical Informatics, 2012
- Prevalence and significance of lactic acidosis in diabetic ketoacidosisJournal of Critical Care, 2012
- Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. a prospective, multiple-center studyCritical Care, 2011
- Metabolic acidosis in patients with severe sepsis and septic shock: A longitudinal quantitative studyCritical Care Medicine, 2009
- Treatment of diabetic ketoacidosis in adults in Denmark: A national surveyDiabetes Research and Clinical Practice, 2007
- Use of base in the treatment of acute severe organic acidosis by nephrologists and critical care physicians: results of an online surveyClinical and Experimental Nephrology, 2006
- Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis in dogsAmerican Journal of Physiology-Renal Physiology, 1985